November 5, 2007 -- LEAD Therapeutics of San Bruno, CA announced a $17 million Series A financing that will underwrite the beginning stages of the company, which promises to leverage the strengths of the US and China in pharma. LEAD has two early-stage projects underway, one in infectious diseases that began in June, and the other in oncology which is just getting started. The article includes an interview with CEO and Chairman Peter Myers, who explains LEAD’s program. More details...
